Primary Aldosteronism Testing Rare in Treatment-Resistant HTN
Patients with apparent treatment-resistant hypertension are rarely tested for primary aldosteronism.
Patients with apparent treatment-resistant hypertension are rarely tested for primary aldosteronism.
Hydrocortisone granules delivered accurate drug dosing to effectively treat pediatric adrenal insufficiency.
Off-label use of glucocorticoids and over-the-counter supplements is common for adrenal fatigue, a condition characterized by a constellation of nonspecific symptoms.
Patients with Cushing syndrome are at an increased risk for infections, including severe COVID-19, due to immunodeficiency and other comorbidities.
High-resolution peripheral quantitative computed tomography can be used to assess bone abnormalities in patients with adrenal incidentaloma.
In patients with classical congenital adrenal hyperplasia, the use of modified-release hydrocortisone may improve biochemical control.
Primary aldosteronism is prevalent and increases in parallel with hypertension severity.
Isturisa is exclusively available through the R.A.R.E.™ Patient Support Program and distributed via AnovoRx specialty pharmacy.
In patients with autoimmune Addison disease, there is a rapid decline in steroidogenic capacity once replacement glucocorticoid medication is started.
The most clinically appropriate mode of hydrocortisone administration during major stress in patients with adrenal insufficiency is continuous intravenous hydrocortisone.